Acessibilidade / Reportar erro

Exploitation of parasite derived antigen in therapeutic success of human cutaneous leishmaniasis in Brazil

Abstract

In a complete study in 25 patients with American cutaneous leishmaniasis, caused by Leishmania braziliensis complex, immunotherapeutic efficacy of parasite derived antigen (94-67 KD) has been compared to antimonial therapy. Additionally, to delineate the mechanism of therapeutic success, microscopical features of immune response in active lesions and healed or non-healed lesions following therapy were analyzed. The results showed that cure rates in immunotherapy and chemoterapy were equal (>83 por cento). The immunohistochemical changes in two therapeutic groups were also largely similar. The analysis of humoral and cellular immune response suggest that appropriate stimulation of T helper cells in the lesion site, in association with one or more cytokines, play a key role in the healing process.

human cutaneous leishmaniasis; Brazil; chemotherapy; immunotherapy


ABSTRACT

Exploitation of parasite derived antigen in therapeutic success of human cutaneous leishmaniasis in Brazil

Loic Monjour1

Asit B. Neogy1

Ioannis Vouldoukis2

Otamires A. Silva1

Sylvie Boisnic3

Maria Edileuza F. Brito4

Annette Lesot3

Nicole Vignot3

Jane S. Martins5

Marcio L. Jardim5

Faculté de Médecine Pitié-Salpétrière, Laboratoire de Parasitologie, Paris, France

Faculté de Médecine Pitié-Salpétrière, Laboratoire de Parasitologie, Paris, Paris, France

Hôpital Pitié-Salpétrière, Département d' Anatomo-Pathologie, Paris, France

FIOCRUZ, Centro de Pesquisas Aggeu Magalhães, Recife, Brasil

UFPE, Departamento de Dermatologia, Recife, Brasil

In a complete study in 25 patients with American cutaneous leishmaniasis, caused by Leishmania braziliensis complex, immunotherapeutic efficacy of parasite derived antigen (94-67 KD) has been compared to antimonial therapy. Additionally, to delineate the mechanism of therapeutic success, microscopical features of immune response in active lesions and healed or non-healed lesions following therapy were analyzed. The results showed that cure rates in immunotherapy and chemoterapy were equal (>83 por cento). The immunohistochemical changes in two therapeutic groups were also largely similar. The analysis of humoral and cellular immune response suggest that appropriate stimulation of T helper cells in the lesion site, in association with one or more cytokines, play a key role in the healing process.

Full text available only in PDF format.

Texto completo disponível apenas em PDF.

Publication Dates

  • Publication in this collection
    15 June 2009
  • Date of issue
    Sept 1994
Instituto Oswaldo Cruz, Ministério da Saúde Av. Brasil, 4365 - Pavilhão Mourisco, Manguinhos, 21040-900 Rio de Janeiro RJ Brazil, Tel.: (55 21) 2562-1222, Fax: (55 21) 2562 1220 - Rio de Janeiro - RJ - Brazil
E-mail: memorias@fiocruz.br